Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today (Monday) in the journal Oncoimmunology*. For the first time, Cancer Research UK researchers at the University of Birmingham have found that certain genetic flaws in bowel cancer are more likely to trigger an immune response at the site of tumours, meaning that treatments to boost this immune response further could potentially be helpful for these patients. Finding out what's happening in a cancer patient's immune system can be difficult and takes time. These findings suggest that genetic profiles of patients' tumours could be used as an easy and fast way of diagnosing whether they are suitable for immunotherapy treatments, and if so which ones. Cancer Research UK's FOCUS4** trial is already using the genetics of bowel cancer to offer patients stratified medicine and this study suggests that we could further expand this work to include immunotherapies. Gary Middleton, Professor of Medical Oncology at the School of Cancer Sciences at the University of Birmingham, said: "The field of immunotherapy is gaining lots of momentum and this study shows a new finding for bowel cancer. … Continue reading →

What is "Stem cell therapy" ? | Steps in PRP Treatment : TV5 News Download TV5 Android App: http://goo.gl/8mMEOX Subscribe to TV5 News Channel: http://goo.gl/NHJD9 Like us on Facebook: http://www.facebook.com/tv5newschannel Follow us on Twitter:... By: TV5 News … Continue reading →

March 26, 2014 Merck Licenses NanoBio Technology Associated Press ANN ARBOR, Mich., -NanoBio Corporationtoday announced a licensing agreement with a subsidiary of Merck &Co., Inc., known as MSD outside the United States and Canada, for theuse of its nanoemulsion (NE) adjuvant technology. Under the agreement, Merck receives exclusive rights to NanoBio's NEadjuvant for use in an intranasal respiratory syncytial virus (RSV)vaccine and non-exclusive rights for use in an intranasal seasonalinfluenza and/or universal seasonal influenza ("Flu") vaccine. NanoBioreceives an upfront payment and is eligible to receive milestonepayments based on Merck RSV and Flu vaccine candidates' developmentand regulatory approvals, as well as royalties on sales of any MerckRSV or Flu vaccines that ultimately use the NanoBio NE adjuvanttechnology. NanoBio's NanoStat@ technology platform employs a novel oil-in-waternanoemulsion that can incorporate, deliver and adjuvant multipleantigen types. The NE adjuvant is effective when administered viaintranasal, intramuscular or subcutaneous vaccination. In recentstudies, NanoBio has demonstrated that intranasal vaccination elicitsrobust systemic and mucosal immunity, thereby offering enhancedprotection against respiratory infections and sexually transmitteddiseases compared to intramuscular vaccination. "We've collaborated with Merck on research in RSV since 2011 and arevery pleased to broaden our relationship with this license agreementcovering vaccine candidates for two respiratory diseases," said DavidPeralta, chief … Continue reading →

The pioneering treatment involves cells taken from a patients own body Theseare then reinjected into their heart to repair damaged muscle Could improve quality of life for patients suffering from heart failure This is caused by heart failing to pump enough blood around the body at the right pressure By Roger Dobson and Katherine Keogh For The Mail On Sunday Published: 17:16 EST, 21 March 2015 | Updated: 18:15 EST, 21 March 2015 261 shares 30 View comments A pioneering treatment that uses stem cells to repair a broken heart could transform the lives of people with a potentially fatal cardiac condition. The 15-minute procedure involves cells taken from a patients own body, which are then reinjected into their heart to repair damaged muscle. It is hoped that the procedure could improve the quality of life for patients suffering from heart failure, which affects 900,000 people in the UK. The condition is caused by the heart failing to pump enough blood around the body at the right pressure, because the muscle has become too weak or stiff to work properly. It causes breathlessness and extreme tiredness, and can even lead to sudden death. Read this article: How stem cells can … Continue reading →